Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 456

1.

Burden of respiratory tract infections at post mortem in Zambian children.

Bates M, Shibemba A, Mudenda V, Chimoga C, Tembo J, Kabwe M, Chilufya M, Hoelscher M, Maeurer M, Sinyangwe S, Mwaba P, Kapata N, Zumla A.

BMC Med. 2016 Jul 1;14(1):99. doi: 10.1186/s12916-016-0645-z.

2.

WHO recommendations on shorter treatment of multidrug-resistant tuberculosis.

Sotgiu G, Tiberi S, D'Ambrosio L, Centis R, Zumla A, Migliori GB.

Lancet. 2016 Jun 18;387(10037):2486-7. doi: 10.1016/S0140-6736(16)30729-2. No abstract available.

PMID:
27353670
3.

'Sample-in, answer-out'? Evaluation and comprehensive analysis of the Unyvero P50 pneumonia assay.

Personne Y, Ozongwu C, Platt G, Basurto-Lozada P, Shamin M, Gant VA, Zumla A, Enne VI.

Diagn Microbiol Infect Dis. 2016 Jun 14. pii: S0732-8893(16)30170-5. doi: 10.1016/j.diagmicrobio.2016.06.010. [Epub ahead of print]

PMID:
27352731
4.

The annual Hajj pilgrimage-minimizing the risk of ill health in pilgrims from Europe and opportunity for driving the best prevention and health promotion guidelines.

Shafi S, Dar O, Khan M, Khan M, Azhar EI, McCloskey B, Zumla A, Petersen E.

Int J Infect Dis. 2016 Jun 22. pii: S1201-9712(16)31097-9. doi: 10.1016/j.ijid.2016.06.013. [Epub ahead of print]

5.

Pathogens, prejudice, and politics: the role of the global health community in the European refugee crisis.

Khan MS, Osei-Kofi A, Omar A, Kirkbride H, Kessel A, Abbara A, Heymann D, Zumla A, Dar O.

Lancet Infect Dis. 2016 Jun 20. pii: S1473-3099(16)30134-7. doi: 10.1016/S1473-3099(16)30134-7. [Epub ahead of print] Review.

PMID:
27339456
6.

Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.

Aseffa A, Chukwu JN, Vahedi M, Aguwa EN, Bedru A, Mebrahtu T, Ezechi OC, Yimer G, Yamuah LK, Medhin G, Connolly C, Rida W, Aderaye G, Zumla AI, Onyebujoh PC; 4FDC Study Group.

PLoS One. 2016 Jun 20;11(6):e0157434. doi: 10.1371/journal.pone.0157434. eCollection 2016.

7.

What is the experience from previous mass gathering events? Lessons for Zika virus and the Olympics 2016.

Zumla A, McCloskey B, Bin Saeed AA, Dar O, Al Otabi B, Perlmann S, Gautret P, Roy N, Blumberg L, Azhar EI, Barbeschi M, Memish Z, Petersen E.

Int J Infect Dis. 2016 Jun 15. pii: S1201-9712(16)31094-3. doi: 10.1016/j.ijid.2016.06.010. [Epub ahead of print]

8.

Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential.

Zumla A, Dar O, Kock R, Muturi M, Ntoumi F, Kaleebu P, Eusebio M, Mfinanga S, Bates M, Mwaba P, Ansumana R, Khan M, Alagaili AN, Cotten M, Azhar EI, Maeurer M, Ippolito G, Petersen E.

Int J Infect Dis. 2016 Jun 15. pii: S1201-9712(16)31096-7. doi: 10.1016/j.ijid.2016.06.012. [Epub ahead of print]

9.

Hosting of mass gathering sporting events during the 2013-2016 Ebola virus outbreak in West Africa: experience from three African countries.

Blumberg L, Regmi J, Endricks T, McCloskey B, Petersen E, Zumla A, Barbeschi M.

Int J Infect Dis. 2016 Jun 15. pii: S1201-9712(16)31095-5. doi: 10.1016/j.ijid.2016.06.011. [Epub ahead of print] No abstract available.

10.

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.

Zumla A, Rao M, Dodoo E, Maeurer M.

BMC Med. 2016 Jun 15;14(1):89. doi: 10.1186/s12916-016-0635-1. Review.

11.

Zika virus and microcephaly: is the correlation causal or coincidental?

Liuzzi G, Puro V, Lanini S, Vairo F, Nicastri E, Capobianchi MR, Di Caro A, Piacentini M, Zumla A, Ippolito G.

New Microbiol. 2016 Apr;39(2):83-5. No abstract available.

12.

Zika virus in saliva-New challenges for prevention of human to human transmission.

Liuzzi G, Nicastri E, Puro V, Zumla A, Ippolito G.

Eur J Intern Med. 2016 May 11. pii: S0953-6205(16)30091-7. doi: 10.1016/j.ejim.2016.04.022. [Epub ahead of print] No abstract available.

PMID:
27179414
13.

Optimizing the benefits of pneumococcal vaccination in the Kingdom of Saudi Arabia.

Azhar EI, Zumla A.

Ann Thorac Med. 2016 Apr-Jun;11(2):91-2. doi: 10.4103/1817-1737.180031. No abstract available.

14.

Post-caesarean section surgical site infections at a Tanzanian tertiary hospital: a prospective observational study.

De Nardo P, Gentilotti E, Nguhuni B, Vairo F, Chaula Z, Nicastri E, Nassoro MM, Bevilacqua N, Ismail A, Savoldi A, Zumla A, Ippolito G.

J Hosp Infect. 2016 Aug;93(4):355-9. doi: 10.1016/j.jhin.2016.02.021. Epub 2016 Mar 11.

PMID:
27125664
15.

Exposed, but Not Protected: More Is Needed to Prevent Drug-Resistant Tuberculosis in Healthcare Workers and Students.

von Delft A, Dramowski A, Sifumba Z, Mosidi T, Xun Ting T, von Delft D, Zumla A.

Clin Infect Dis. 2016 May 15;62 Suppl 3:S275-80. doi: 10.1093/cid/ciw037.

PMID:
27118858
16.

Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015.

Atabani SF, Wilson S, Overton-Lewis C, Workman J, Kidd IM, Petersen E, Zumla A, Smit E, Osman H.

Int J Infect Dis. 2016 Apr 23. pii: S1201-9712(16)31030-X. doi: 10.1016/j.ijid.2016.04.016. [Epub ahead of print]

17.

To have sepsis or to be septic-is the difference between these clinical conditions important?

Petersen E, Zumla A.

Int J Infect Dis. 2016 Jul;48:118-9. doi: 10.1016/j.ijid.2016.04.018. Epub 2016 Apr 23. No abstract available.

18.

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Abdo Arbex M, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Auchynka V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Jun;47(6):1758-66. doi: 10.1183/13993003.00214-2016. Epub 2016 Apr 13.

PMID:
27076583
19.

Reducing risks to health and wellbeing at mass gatherings: the role of the Sendai Framework for Disaster Risk Reduction.

Aitsi-Selmi A, Murray V, Heymann D, McCloskey B, Azhar EI, Petersen E, Zumla A, Dar O.

Int J Infect Dis. 2016 Apr 7. pii: S1201-9712(16)31019-0. doi: 10.1016/j.ijid.2016.04.006. [Epub ahead of print]

20.

Progress towards achieving global tuberculosis control: so near, yet so far.

Zumla A, Davies PD.

Int J Tuberc Lung Dis. 2016 Mar;20(3):285-6. doi: 10.5588/ijtld.15.1004. No abstract available.

PMID:
27046703
Items per page

Supplemental Content

Write to the Help Desk